See also this year's filing and all EDGAR filings for this company.
PDF Report 0001373707_2015_Tetraphase_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001373707, Tetraphase Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 126,597,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 300,000 |
| 3 | remainder_Assets | 307,000 |
| 4 | LiabilitiesCurrent | 17,276,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,932,000 |
| 9 | ResearchAndDevelopmentExpense | 61,932,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 9,098,000 |
| 12 | remainder_NetIncome | -976,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 127,204,000 |
| 1 | Liabilities | 17,276,000 |
| 2 | Expenses | 74,864,000 |
| 3 | Revenues | 9,098,000 |
| 4 | StockholdersEquity | 109,928,000 |
| 5 | NetIncome | -66,742,000 |
| 6 | ComprehensiveNetIncome | -66,742,000 |
| 7 | BaseVar | 114,709,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.39 |
| 9 | EconomicCapitalRatio | 3.29 |